Research.Patient.info
Relapsed and refractory multiple myeloma (RRMM) research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A Trial to Determine the Safety of CC-93269, an Antibody, in People who have Multiple Myeloma That Has Returned After a Period of Treatment And is not Responsive After Treatment.
This study is looking at a new treatment called CC-93269 for people with a type of blood cancer called multiple myeloma. It's for patients whose cancer has come back and isn't responding to other treatments. The main goal is to check if this new treatment is safe to use in people.
Spain · Germany · Sweden - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 1/2 Multicenter, Open-label Study to Assess the Safety, Pharmacokinetics and Efficacy of CC-92480 Monotherapy and in Combination with Dexamethasone in Subjects with Relapsed and Refractory Multiple Myeloma
This study is looking at a new drug, CC-92480, for people with multiple myeloma that has come back or not responded to previous treatments. It aims to see how safe the drug is, how it moves through the body, and how well it works, both on its own and with another medicine called dexamethasone.
Belgium · Spain